|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7250 NOK | 0.00% |
|
-3.33% | -47.46% |
| Jun. 30 | Exact Therapeutics to Delist from Euronext Growth Oslo in October | MT |
| Jun. 26 | EXACT Therapeutics AS Gets Positive Safety Review For 60 ?l/Kg Dose In Phase 2 ENACT Trial | RE |
| Market Cap | 45.87M 4.75M 4.15M 3.84M 3.52M 6.66M 457M 6.78M 45.75M 17.97M 223M 17.82M 17.43M 771M | P/E 2024 |
-2.49x | P/E 2025 | -1x |
|---|---|---|---|---|---|
| Enterprise Value | 21.95M 2.27M 1.99M 1.84M 1.68M 3.19M 219M 3.24M 21.9M 8.6M 107M 8.53M 8.34M 369M | EV / Sales 2024 |
-
| EV / Sales 2025 | 1,074,437,000x |
| Free-Float |
30.97% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | -3.33% | ||
| Current month | -11.04% | ||
| 1 month | -9.38% | ||
| 3 months | -52.92% | ||
| 6 months | -69.54% | ||
| Current year | -47.46% |
| 1 week | 0.66 |  | 0.75 |
| 1 month | 0.65 | | 0.88 |
| Current year | 0.58 | | 2.7 |
| 1 year | 0.58 | | 3 |
| 3 years | 0.58 | | 20 |
| 5 years | 0.58 | | 24 |
| 10 years | 0.58 | | 53.59 |
| Manager | Title | Age | Since |
|---|---|---|---|
Svein Kvåle
COO | Chief Operating Officer | - | 2011-12-31 |
Per Walday
CEO | Chief Executive Officer | 66 | 2022-06-05 |
John Edminson
DFI | Director of Finance/CFO | - | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 55 | 2018-06-21 | |
Anders Wold
CHM | Chairman | - | 2022-06-07 |
| Director/Board Member | 59 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/4/23 | Buy | Founder | 2,500 | 0.0083% | ||
| 1/4/23 | Buy | Chief Technology Officer | 2,500 | 0.0083% | ||
| 1/4/23 | Buy | Chairman | 2,500 | 0.0083% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -3.33% | -73.92% | -93.70% | 4.74M | |
| -1.07% | -1.27% | +0.95% | +6.28% | 50.35B | |
| -3.11% | -6.29% | +366.42% | +573.07% | 39.21B | |
| +1.45% | +0.06% | +31.80% | -5.55% | 34.52B | |
| +1.90% | +4.37% | +13.22% | +59.71% | 34.6B | |
| +0.06% | -0.57% | +3.35% | +27.42% | 27.05B | |
| -1.93% | -4.32% | - | - | 16.68B | |
| +0.94% | -0.47% | +69.30% | +115.48% | 15.11B | |
| +0.29% | +1.02% | +14.95% | +18.32% | 13.85B | |
| -1.30% | +0.72% | +18.02% | -30.63% | 13.18B | |
| Average | -0.33% | +0.40% | +49.34% | +74.49% | 24.46B | |
| Weighted average by Cap. | -0.46% | +0.70% | +77.03% | +118.48% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 0.06 0.01 0.01 0 0 0.01 0.59 0.01 0.06 0.02 0.29 0.02 0.02 0.99 |
| Net income | -52.33M -5.41M -4.73M -4.38M -4.02M -7.6M -522M -7.73M -52.19M -20.5M -255M -20.33M -19.89M -880M | -86.97M -9M -7.86M -7.27M -6.67M -12.63M -867M -12.85M -86.74M -34.07M -423M -33.79M -33.05M -1.46B |
| Net Debt | -98.89M -10.23M -8.94M -8.27M -7.59M -14.36M -986M -14.61M -98.63M -38.75M -481M -38.42M -37.58M -1.66B | -23.91M -2.47M -2.16M -2M -1.84M -3.47M -238M -3.53M -23.85M -9.37M -116M -9.29M -9.09M -402M |
Employees
11
Calendar
Sep. 02 -
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-16 | NOK 0.7250 | 0.00% | 584 |
| 26-07-15 | NOK 0.7250 | +9.02% | 44,788 |
| 26-07-14 | NOK 0.6650 | -1.48% | 5,250 |
| 26-07-13 | NOK 0.6750 | 0.00% | 0 |
| 26-07-10 | NOK 0.6750 | -10.00% | 64,192 |
- Stock Market
- Stocks
- EXTX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
